BioCentury | Jun 11, 2012
Company News

Medigene, Cowen Healthcare Royalty Partners L.P. deal

...MediGene sold Cowen Healthcare Royalty Partners a 2% royalty on European sales of Eligard leuprolide for $17.7 million in...
...Phase II trials in triple-negative breast cancer and pancreatic cancer. MediGene AG (Xetra:MDG), Martinsried, Germany Cowen Healthcare Royalty Partners...
BioCentury | Jun 11, 2012
Finance

Highlights of weekly biotech stock moves

...million, plus royalties. MediGene AG (Xetra:MDG) was up €0.04 to €1.17 last week after selling Cowen Healthcare Royalty Partners...
BioCentury | Jun 8, 2012
Company News

MediGene sells Eligard royalties

...MediGene AG (Xetra:MDG) sold Cowen Healthcare Royalty Partners a 2% royalty on European sales of Eligard leuprolide for $17.7...
BioCentury | Jan 9, 2012
Financial News

Dyax completes debt financing

...Mass. Business: Inflammation, Ophthalmic, Antibodies Date completed: 1/4/12 Type: Debt financing Raised: $20 million Investor: Cowen Healthcare Royalty Partners...
BioCentury | Jan 9, 2012
Finance

Treated like royalty

...The $1 billion close for Cowen Healthcare Royalty Partners ' second fund makes it crystal clear that LPs want...
BioCentury | Jan 9, 2012
Financial News

Cowen Healthcare Royalty Partners L.P. financial update

...Cowen Healthcare Royalty Partners closed its second fund, Cowen Healthcare Royalty Partners II, at $1 billion. The firm said...
...Suisse was an advisor and placement agent. Cowen Royalty has over $1.5 billion under management. Cowen Healthcare Royalty Partners...
BioCentury | Jan 6, 2012
Top Story

Cowen Royalty closes $1B fund

...Cowen Healthcare Royalty Partners closed its second fund, Cowen Healthcare Royalty Partners II, at $1 billion. The firm said...
BioCentury | Jan 2, 2012
Company News

Santarus, Shore Therapeutics sales and marketing update

...a subsidiary of Shionogi & Co. Ltd. (Tokyo:4507; Osaka:4507, Osaka, Japan), under a 2007 deal. Cowen Healthcare Royalty Partners...
BioCentury | Jul 11, 2011
Financial News

Zogenix completes debt financing

...San Diego, Calif. Business: Neurology Date completed: 6/30/11 Type: Debt financing Raised: $30 million Investor: Cowen Healthcare Royalty Partners...
BioCentury | Jul 11, 2011
Financial News

Zogenix completes private placement

...Private placement Raised: $1.5 million Shares: 388,601 Price: $3.86 Shares after offering: 34.4 million Investor: Cowen Healthcare Royalty Partners...
Items per page:
1 - 10 of 38
BioCentury | Jun 11, 2012
Company News

Medigene, Cowen Healthcare Royalty Partners L.P. deal

...MediGene sold Cowen Healthcare Royalty Partners a 2% royalty on European sales of Eligard leuprolide for $17.7 million in...
...Phase II trials in triple-negative breast cancer and pancreatic cancer. MediGene AG (Xetra:MDG), Martinsried, Germany Cowen Healthcare Royalty Partners...
BioCentury | Jun 11, 2012
Finance

Highlights of weekly biotech stock moves

...million, plus royalties. MediGene AG (Xetra:MDG) was up €0.04 to €1.17 last week after selling Cowen Healthcare Royalty Partners...
BioCentury | Jun 8, 2012
Company News

MediGene sells Eligard royalties

...MediGene AG (Xetra:MDG) sold Cowen Healthcare Royalty Partners a 2% royalty on European sales of Eligard leuprolide for $17.7...
BioCentury | Jan 9, 2012
Financial News

Dyax completes debt financing

...Mass. Business: Inflammation, Ophthalmic, Antibodies Date completed: 1/4/12 Type: Debt financing Raised: $20 million Investor: Cowen Healthcare Royalty Partners...
BioCentury | Jan 9, 2012
Finance

Treated like royalty

...The $1 billion close for Cowen Healthcare Royalty Partners ' second fund makes it crystal clear that LPs want...
BioCentury | Jan 9, 2012
Financial News

Cowen Healthcare Royalty Partners L.P. financial update

...Cowen Healthcare Royalty Partners closed its second fund, Cowen Healthcare Royalty Partners II, at $1 billion. The firm said...
...Suisse was an advisor and placement agent. Cowen Royalty has over $1.5 billion under management. Cowen Healthcare Royalty Partners...
BioCentury | Jan 6, 2012
Top Story

Cowen Royalty closes $1B fund

...Cowen Healthcare Royalty Partners closed its second fund, Cowen Healthcare Royalty Partners II, at $1 billion. The firm said...
BioCentury | Jan 2, 2012
Company News

Santarus, Shore Therapeutics sales and marketing update

...a subsidiary of Shionogi & Co. Ltd. (Tokyo:4507; Osaka:4507, Osaka, Japan), under a 2007 deal. Cowen Healthcare Royalty Partners...
BioCentury | Jul 11, 2011
Financial News

Zogenix completes debt financing

...San Diego, Calif. Business: Neurology Date completed: 6/30/11 Type: Debt financing Raised: $30 million Investor: Cowen Healthcare Royalty Partners...
BioCentury | Jul 11, 2011
Financial News

Zogenix completes private placement

...Private placement Raised: $1.5 million Shares: 388,601 Price: $3.86 Shares after offering: 34.4 million Investor: Cowen Healthcare Royalty Partners...
Items per page:
1 - 10 of 38